Brief: Mymd Pharma Provides Update On Phase 2 Trial Of Therapy For Delaying Aging And Extending Healthy Lifespan
12/04/2023 13:58
April 12 (Reuters) - MyMD Pharmaceuticals Inc MYMD.O :
* MYMD PHARMACEUTICALS® PROVIDES DOSING UPDATE ON PHASE 2
MULTI-CENTER CLINICAL TRIAL OF MYMD-1® AS A THERAPY FOR DELAYING
AGING AND EXTENDING HEALTHY LIFESPAN
* MYMD PHARMACEUTICALS INC - SAFETY REVIEW COMMITTEE HAS
CONFIRMED NO SAFETY OR TOXICITY ISSUES WITH FIRST 30 PATIENTS
ENROLLED IN THIS STUDY
* MYMD PHARMACEUTICALS - SAFETY REVIEW COMMITTEE HAS VOTED
UNANIMOUSLY TO ESCALATE TO FINAL DOSE LEVEL IN STUDY
Source text for Eikon: ID:nBw9rMjLBa
Further company coverage: MYMD.O
((Reuters.Briefs@thomsonreuters.com;))